Applovin
APP
281.29
+2.51
+0.90%
Applovin
US · APP
#193 by market cap
Listed 2021
281.29
+2.51
+0.90%
Live - 5344 symbols - heartbeat 99s ago
· 2026-10-08 08:29
Pre-market
276.91
-1.56%
After-hours
281.00
-0.10%
Overnight
277.53
-1.34%
- Market cap
- 94.13B
- P/E (TTM)i
- 21.62
- P/Bi
- 29.76
- EPSi
- 9.75
- Div yieldi
- 0.00%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on APP?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 14.51, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 7 years
Latest year +69.99% YoY
Margins
- Gross margin
- 87.86%
- Operating margin
- 75.75%
- Net margin
- 60.82%
Key ratios & quality
- Enterprise valuei
- 95.17B
- Altman Z-Scorei
- 14.51
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 994.10M | 1.45B | 2.79B | 2.82B | 1.84B | 3.22B | 5.48B |
| Gross profit | 752.83M | 895.51M | 1.81B | 1.56B | 1.49B | 2.70B | 4.82B |
| Selling & admin expenses | 513.49M | 694.23M | 1.29B | 1.10B | 378.96M | 417.78M | 437.15M |
| Research & development | 44.97M | 180.65M | 366.40M | 507.61M | 333.78M | 374.71M | 226.51M |
| Operating profit | 194.37M | 20.63M | 150.02M | -47.79M | 772.41M | 1.91B | 4.15B |
| Pretax profit | 126.23M | -135.71M | 46.31M | -205.18M | 501.60M | 1.61B | 3.95B |
| Tax | 7.19M | -9.77M | 10.97M | -12.23M | 43.78M | 22.42M | 519.72M |
| Net profit | 119.04M | -125.93M | 35.34M | -192.95M | 357.21M | 1.58B | 3.33B |
| Basic EPS | 0 | 0 | 0 | -1 | 1 | 5 | 10 |
| Diluted EPS | 0.24 | -0.35 | 0.09 | -0.52 | 0.98 | 4.53 | 9.75 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.16B | 1.26B | 1.41B | 1.66B | 1.84B | 1.92B |
| Gross profit | 1.01B | 1.10B | 1.23B | 1.47B | 1.64B | 1.70B |
| Selling & admin expenses | 110.91M | 101.96M | 107.33M | 116.95M | 104.78M | 103.71M |
| Research & development | 56.41M | 44.03M | 43.85M | 82.22M | 94.10M | 99.90M |
| Operating profit | 839.98M | 957.68M | 1.08B | 1.28B | 1.44B | 1.49B |
| Pretax profit | 794.61M | 884.00M | 1.02B | 1.25B | 1.43B | 1.51B |
| Tax | 71.07M | 112.15M | 185.40M | 151.10M | 225.80M | 238.99M |
| Net profit | 576.42M | 819.53M | 835.55M | 1.10B | 1.21B | 1.27B |
| Basic EPS | 2 | 2 | 2 | 3 | 4 | 4 |
| Diluted EPS | 1.67 | 2.39 | 2.45 | 3.24 | 3.56 | 3.76 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | 586.22M | 662.99M | 3.24B | 1.94B | 1.62B | 2.31B | 4.43B |
| Cash & ST investments | 396.25M | 317.24M | 1.52B | 1.08B | 502.15M | 697.03M | 2.49B |
| Inventory | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.20B | 2.15B | 6.16B | 5.85B | 5.36B | 5.87B | 7.26B |
| Total current liabilities | 238.88M | 598.05M | 640.10M | 578.96M | 944.12M | 1.06B | 1.33B |
| Short-term debt | 14.72M | 40.24M | 66.20M | 47.64M | 228.61M | 14.53M | 13.94M |
| Long-term debt | 1.17B | 1.58B | 3.20B | 3.18B | 2.91B | 3.51B | 3.51B |
| Total liabilities | 1,459,052,000.00 | 2,312,829,000.00 | 4,025,288,000.00 | 3,945,169,000.00 | 4,102,858,000.00 | 4,779,441,000.00 | 5,124,939,000.00 |
| Total equity | -256.57M | -158.24M | 2.14B | 1.90B | 1.26B | 1.09B | 2.13B |
| Retained earnings | -887.21M | -1.01B | -976.95M | -1.17B | -812.99M | 599.20M | 1.74B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.37B | 2.99B | 3.49B | 4.43B | 4.85B | 5.39B |
| Cash & ST investments | 551.02M | 1.19B | 1.67B | 2.49B | 2.76B | 3.05B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 5.71B | 5.96B | 6.34B | 7.26B | 7.71B | 8.27B |
| Total current liabilities | 1.41B | 1.09B | 1.07B | 1.33B | 1.49B | 1.25B |
| Short-term debt | 200.00M | -- | -- | 13.94M | -- | -- |
| Long-term debt | 3.51B | 3.51B | 3.51B | 3.51B | 3.51B | 3.52B |
| Total liabilities | 5,131,280,000.00 | 4,792,370,000.00 | 4,869,115,000.00 | 5,124,939,000.00 | 5,344,222,000.00 | 5,106,115,000.00 |
| Total equity | 575.42M | 1.17B | 1.47B | 2.13B | 2.36B | 3.16B |
| Retained earnings | 173.95M | 723.37M | 1.05B | 1.74B | 1.93B | 2.66B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 198.46M | 222.88M | 361.85M | 412.77M | 1.06B | 2.10B | 3.97B |
| Depreciation & amortization | 92.81M | 254.95M | 431.06M | 547.08M | 489.01M | 448.68M | 194.78M |
| Free cash flow | 195.10M | 219.64M | 360.46M | 412.11M | 997.61M | 2.07B | 3.94B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -11.00K | 7.55M | 1.75B | -338.88M | -1.15B | -981.30M | -2.19B |
| Ending cash balance | 396.25M | 317.24M | 2.57B | 1.08B | 502.15M | 741.41M | 2.49B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 831.71M | 772.23M | 1.05B | 1.31B | 1.29B | 869.04M |
| Depreciation & amortization | 79.89M | 47.05M | 35.10M | 32.74M | 33.67M | 32.56M |
| Free cash flow | 831.71M | 772.23M | 1.05B | 1.29B | 1.29B | 869.04M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -1.00B | -271.52M | -501.90M | -417.62M | -981.72M | -551.23M |
| Ending cash balance | 542.52M | 1.19B | 1.67B | 2.49B | 2.76B | 3.05B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | 4.01 | -9.54 | 22.47 | 134.44 | 206.75 |
| ROA %i | 6.35 | -7.46 | 0.76 | -3.21 | 6.33 | 28.09 | 50.78 |
| ROIC %i | -- | -- | 3.34 | -0.58 | 12.73 | 39.95 | 68.05 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | 71.63 |
| EBIT margin %i | 20.14 | -3.99 | 5.35 | -1.18 | 19.99 | 40.22 | 75.90 |
| FCF / sales %i | 19.63 | 15.14 | 12.76 | 14.42 | 32.20 | 44.47 | 71.94 |
| Current ratioi | 2.45 | 1.11 | 5.05 | 3.35 | 1.71 | 2.19 | 3.32 |
| Quick ratioi | 2.33 | 1.03 | 3.18 | 3.08 | 1.54 | 1.87 | 3.23 |
| Debt / assetsi | 99.45 | 78.71 | 54.04 | 56.09 | 59.29 | 60.56 | 48.83 |
| LT debt / equityi | -- | -- | 152.68 | 169.90 | 234.72 | 324.83 | 165.40 |
| Interest coveragei | 2.71 | -0.74 | 1.45 | -0.19 | 2.38 | 5.95 | 20.09 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 41.51 | 8.27 | 4.90 | 24.84 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | 254.55 | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | 28.31 | 65.61 | 79.18 | 112.29 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 287.30 | 245.04 | 234.63 | 206.75 | 269.67 | 203.68 |
| ROA %i | 34.98 | 43.25 | 48.02 | 50.78 | 59.08 | 61.99 |
| ROIC %i | 51.68 | 59.92 | 65.08 | 68.05 | 83.06 | 80.72 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 43.30 | 50.88 | 54.68 | 75.90 | 77.79 | 79.31 |
| FCF / sales %i | 49.33 | 49.69 | 53.17 | 71.94 | 71.42 | 65.88 |
| Current ratioi | 1.68 | 2.74 | 3.25 | 3.32 | 3.24 | 4.30 |
| Quick ratioi | 1.51 | 2.54 | 3.05 | 3.23 | 3.16 | 4.17 |
| Debt / assetsi | 65.01 | 58.91 | 55.37 | 48.83 | 45.59 | 42.51 |
| LT debt / equityi | 609.98 | 300.82 | 238.27 | 165.40 | 148.68 | 111.13 |
| Interest coveragei | 7.49 | 10.65 | 13.76 | 20.09 | 23.36 | 26.42 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
End-to-end advertising solutions through Axon Ads Manager, MAX, Adjust, and Wurl100.00%
Quote time 2026-10-08 08:29:16 · For reference only, not investment advice and not tailored to your situation.